Clinical Trial Update: Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

View source ↗

Summary

This clinical trial update describes a Shanghai Chest Hospital study analyzing the molecular landscape of non-small cell lung cancer patients with rare mutation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: NSCLC, NSCLC Stage IV | Status: RECRUITING